Business MSF’s costing study says newer diabetes drugs and insulin pens priced beyond patient reach Posted on March 27, 2024 by miyuru Home Business Upgraded – March 27, 2024 at 09:43 PM. The research study’s very first finding included a more recent class of drugs, GLP-1s, consisting of Ozempic and Trulicity marketed….
